Atorvastatin Epoxy Pyrrolooxazin 7-Hydroxy Analog

CAS No :

1315629-79-8 (KLS-A06002)

Molecular Formula:

C33H35FN2O7

Molecular Weight:

556.6

Chemical Name:

(3R)-4-(1b-(4-Fluorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-1aH-oxireno[2′,3′:3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoic acid

Add to Enquiry Basket
Product Enquiry

Related Products

Difluoro Atorvastatin Acetonide tert-Butyl Ester

CAS No: ​693793-87-2

Molecular Formula:​ C40H46F2N2O5

Molecular Weight: ​672.8

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity K

CAS No: ​345891-62-5

Molecular Formula:​ C34H37FN2O5

Molecular Weight: ​572.67

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Calcium Trihydrate

CAS No: ​134523-03-8

Molecular Formula:​ C33H34FN2O5

Molecular Weight: ​557.63

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Difluoro Impurity

CAS No: ​693793-82-7

Molecular Formula:​ C26H23F2NO3

Molecular Weight: ​435.47

Inv. Status:​


Add to Enquiry Basket

Atorvastatin 2,3-Anhydro Lactone

CAS No: ​442851-50-5

Molecular Formula:​ C33H31FN2O3

Molecular Weight: ​522.6

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity I

CAS No: ​125971-95-1

Molecular Formula:​ C40H47FN2O5

Molecular Weight: ​654.81

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity C

CAS No: ​693793-53-2

Molecular Formula:​ C33H34F2N2O5 : Ca

Molecular Weight: ​576.6 : 1/2(40.1)

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity A

CAS No: ​1516864-05-3

Molecular Formula:​ C33H35N2O5 : Na

Molecular Weight: ​539.7 : 23.0

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity F

CAS No: ​887196-24-9 (acid) ; 1105067-87-5

Molecular Formula:​ C40H47FN3NaO8

Molecular Weight: ​739.8

Inv. Status:​


Add to Enquiry Basket

API – Impurities | Specialty Chemicals

Dribbble Pinterest

About

Kemiezen Lifesciences is established with a zeal of support the world with the best chemistry solutions with a group of dedicated scientists having 15 years of experience in the pharmaceutical industry.

Contact Us